NCT05846360 is a clinical trial in Respiratory Viral Infection, sponsored by University of Wisconsin, Madison.

Who is sponsoring NCT05846360?

NCT05846360 is sponsored by University of Wisconsin, Madison.

What condition does NCT05846360 study?

NCT05846360 studies Respiratory Viral Infection.

Is NCT05846360 still recruiting?

NCT05846360 is currently completed. Last updated 27 October 2023.

Last reviewed 2023-10-27 · How we verify

NCT05846360

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer

Completed Last updated 27 October 2023

What this trial tests

trial in Respiratory Viral Infection in 120 participants. Completed in 10 October 2023.

Timeline

5 May 2023

Primary endpoint
24 August 2023

10 October 2023

Quick facts

Lead sponsor	University of Wisconsin, Madison
Status	Completed
Study type	OBSERVATIONAL
Enrollment	120
Start date	5 May 2023
Primary completion	24 August 2023
Estimated completion	10 October 2023
Sites	1 location across United States

Conditions studied

Respiratory Viral Infection — all drugs for Respiratory Viral Infection →

Sponsor

University of Wisconsin, Madison

Who can join

Adults 4 to 18, any sex, with Respiratory Viral Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is for the research team to become familiar with and evaluate the technical and operational performance of the QuidelOrtho Savanna RVP4 analyzer by testing 120 archived specimens that were previously tested at the Wisconsin State Laboratory of Hygiene (WSLH) by RT-PCR and multiplex respiratory pathogen panel within the last year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Viral Infection

Currently open trials in the same condition.

NCT07357051 — Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Pa · Phase 3 · recruiting
NCT06417762 — Dime La VerDAD: Verify, Debunk, and Disseminate · NA · recruiting
NCT05913700 — Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study) · active not recruiting
NCT04826991 — Wells and Enteric Disease Transmission · NA · active not recruiting
NCT04482673 — Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection · Phase 4 · active not recruiting

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
NCT07470723 — The ORIGIN-FH Study · NA · recruiting
NCT06975657 — Well-being Skills for Reentry · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05846360 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
Last refreshed: 27 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05846360.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing